The board of directors of pharmaceutical company Eli Lilly and Company (NYSE:LLY) on Monday declared a dividend of USD1.50 per share of common stock for the second quarter of 2025.
This amount is unchanged from the first quarter.
Shareholders of record at the close of business on 16 May 2025 will receive the dividend on 10 June 2025.
Lilly declares Q2 2025 dividend
Bruker acquires majority stake in RECIPE to expand clinical mass spectrometry diagnostics
Emmaus Life Sciences reports drop in revenues, increased loss in 2024
L'Oréal and WHO Foundation partner to expand global skin health access